583 related articles for article (PubMed ID: 16008818)
1. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Ince PG; Codd GA
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
[TBL] [Abstract][Full Text] [Related]
2. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
3. Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Cox PA; Banack S; Murch S; Sacks O
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):679-82. PubMed ID: 17083482
[No Abstract] [Full Text] [Related]
4. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
[TBL] [Abstract][Full Text] [Related]
5. Animal models of BMAA neurotoxicity: a critical review.
Karamyan VT; Speth RC
Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
[TBL] [Abstract][Full Text] [Related]
6. Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Wilson J; Shaw CA
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):341-3. PubMed ID: 16640652
[No Abstract] [Full Text] [Related]
7. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Steele JC; McGeer PL
Neurology; 2008 May; 70(21):1984-90. PubMed ID: 18490618
[TBL] [Abstract][Full Text] [Related]
8. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC.
Wilson JM; Petrik MS; Moghadasian MH; Shaw CA
Can J Physiol Pharmacol; 2005 Feb; 83(2):131-41. PubMed ID: 15791286
[TBL] [Abstract][Full Text] [Related]
9. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002
[TBL] [Abstract][Full Text] [Related]
10. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
[TBL] [Abstract][Full Text] [Related]
11. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
Cox PA; Banack SA; Murch SJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
Sebeo J; Hof PR; Perl DP
Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
[TBL] [Abstract][Full Text] [Related]
13. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Bradley WG; Banack SA; Cox PA
Neurology; 2009 Feb; 72(5):473-4, 476; author reply 475-6. PubMed ID: 19195084
[No Abstract] [Full Text] [Related]
14. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
15. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Cruz-Aguado R; Shaw CA
Neurology; 2009 Feb; 72(5):474, 476; author reply 475-6. PubMed ID: 19195085
[No Abstract] [Full Text] [Related]
16. [Lessons from Guam ALS/PDC study].
Asao H
Rinsho Shinkeigaku; 2007 Nov; 47(11):717-21. PubMed ID: 18210783
[TBL] [Abstract][Full Text] [Related]
17. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
Rao SD; Banack SA; Cox PA; Weiss JH
Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
[TBL] [Abstract][Full Text] [Related]
18. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
19. Parkinsonism-dementia complex of Guam.
Steele JC
Mov Disord; 2005 Aug; 20 Suppl 12():S99-S107. PubMed ID: 16092098
[TBL] [Abstract][Full Text] [Related]
20. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
Banack SA; Cox PA
Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
